Clinical Trials · NCT03419234
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Enrollment
- 223
- Start date
- Apr 2018
- Locations
- 672 sites, United States, Puerto Rico
- Primary endpoint
- Progression-free Survival (PFS)